Skip to main content

Table 3 The univariate analysis of prognosis related factors on 272 postterm choriocarcinoma patients

From: Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study

Clinical and demographics characteristics

5-year survival rate(%)

P value

Age

  

   <40 (n = 250)

88.0

 

   ≥40 (n = 22)

72.7

0.13

Medical history of molar gestation

  

   Yes (n = 48)

84.3

 

   No (n = 224)

87.1

0.70

Interval from index pregnancy,month

  

   ≤12 (n = 161)

93.2

 

   >12 (n = 111)

79.0

0.01

Pretreatment β-hCG,mIU/ml

  

   <100,000 (n = 220)

84.9

 

   ≥ 100,000 (n = 52)

94.0

0.34

   <400,000 (n = 257)

86.3

 

   ≥ 400,000 (n = 15)

93.3

0.79

Metastatic sites

  

   1 (n = 195)

91.0

 

   ≥2 (n = 77)

75.9

0.004

Abnormal uterine bleeding only

  

   Yes (n = 139)

88.4

 

   No (n = 133)

82.8

0.344

Fetal death or stillbirth

  

   Yes (n = 14)

92.9

 

   No (n = 258)

86.2

0.66

Resistance to multiagent chemotherapy

  

   Yes (n = 121)

76.3

 

   No (n = 151)

95.3

0.004

Brain metastasis

  

   Yes (n = 41)

80.6

 

   No (n = 231)

87.9

0.13

Kidney metastasis

  

   Yes (n = 6)

83.3

 

   No (n = 266)

86.7

0.55

Liver metastasis

  

   Yes (n = 10)

33.3

 

   No (n = 262)

89.0

0.000

Surgeries

  

   Yes (n = 141)

85.5

 

   No (n = 131)

87.4

0.25

FIGO score

  

   ≤12 (n = 216)

90.9

 

   >12 (n = 56)

71.3

0.000